![Stephen F. Carroll](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen F. Carroll
Corporate Officer/Principal bei Lypro Biosciences, Inc.
Profil
Stephen F.
Carroll is currently the Director of Discovery & Development at Lypro Biosciences, Inc. He previously worked as a Member at XOMA (US) LLC and as an Assistant Professor of Microbiology & Genetics at Harvard Medical School.
Aktive Positionen von Stephen F. Carroll
Unternehmen | Position | Beginn |
---|---|---|
Lypro Biosciences, Inc.
![]() Lypro Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lypro Biosciences Inc. operates as a therapeutic development company whose proprietary drug delivery nanotechnology increases the solubility and bioavailability of hydrophobic drugs and other therapeutic compounds and facilitates targeting to specific receptor. Its product pipeline includes therapies for infectious diseases such as aspergillosis and leishmaniasis, as well as for cancer such as mantle cell lymphoma. The company was founded by Michael Oda, Murray P Brozinsky and Robert O. Ryan in 2004 and is headquartered in Berkeley, CA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Stephen F. Carroll
Unternehmen | Position | Ende |
---|---|---|
XOMA (US) LLC
![]() XOMA (US) LLC Pharmaceuticals: MajorHealth Technology XOMA (US) LLC develops pharmaceutical preparations. It offers proprietary drugs and toiletries. The company is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
Harvard Medical School | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Lypro Biosciences, Inc.
![]() Lypro Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lypro Biosciences Inc. operates as a therapeutic development company whose proprietary drug delivery nanotechnology increases the solubility and bioavailability of hydrophobic drugs and other therapeutic compounds and facilitates targeting to specific receptor. Its product pipeline includes therapies for infectious diseases such as aspergillosis and leishmaniasis, as well as for cancer such as mantle cell lymphoma. The company was founded by Michael Oda, Murray P Brozinsky and Robert O. Ryan in 2004 and is headquartered in Berkeley, CA. | Health Technology |
XOMA (US) LLC
![]() XOMA (US) LLC Pharmaceuticals: MajorHealth Technology XOMA (US) LLC develops pharmaceutical preparations. It offers proprietary drugs and toiletries. The company is headquartered in Emeryville, CA. | Health Technology |